"I bought 10,000 shares of yesterday's pick, at $0.75 and sold all my shares at $0.98, I didn't sell at your recommended target price but I'm definitely with 8.36% profit, that may seem like a lot but I don't know anybody personally who can make an 8% profit in one day. I'm going to get rich trading your stocks."
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Can Aperture Health Inc. (OTCBB: APRE) Clean Up Past Mess and Become a Player in Home Healthcare Industry?
Posted on June 18, 2012 by OTC Equity
Aperture Health Inc. (OTCBB: APRE), which operates as a fully JCAHO accredited home IV therapy company through its wholly owned subsidiary Triad Therapeutics, started the week off on the right foot, climbing as high as 0.070 after trading as low as 0.028 last Friday. Along with the share price spike APRE has seen volume skyrocket, surpassing the 4.1 million mark by mid-afternoon, significantly higher than their 50-day average of 235,000. Triggering the activity on Monday has been a promotional campaign playing off of APRE's press release announcing the execution of a Letter of Intent to acquire Doctors on Call, "one of the largest in-home medical practices in New York City." While Dr. Paul Rosenstock, CEO and Medical Director of Doctors on Call, stated in the release, "We are excited with the affiliation with Aperture Health for it allows Doctors on Call to rapidly expand b...
To read the complete article sign up below; registration is free, you will only be asked to provide a valid email.
If you are not a registered user, registration is quick and easy - simply enter your email below and you are registered to view OTCEquity's Exclusive content. Your registration and membership is FREE, so register below now.
OTCEquity.com Exclusive Content |
|
|---|---|
| Read Disclaimer |

